Insider · CIK 0001563584
John M Leonard
Files at IQV (IQVIA HOLDINGS INC.), NTLA (Intellia Therapeutics, Inc.). First filing Jan 7, 2025, latest Dec 12, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | Intellia Therapeutics, Inc. | $836k 88,146 shares | -8% | +52% from low-66% from high | |
| 55Moderate | Intellia Therapeutics, Inc. | $327k 26,807 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +49,959 | $6.83 | $341k | 1,127,074 | Dec 12, 2025 |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -49,959 | $9.49 | $474k | 1,077,115 | Dec 12, 2025 |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -32,832 | $9.47 | $311k | 1,044,283 | Dec 12, 2025 |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,355 | $9.59 | $51k | 1,038,928 | Dec 12, 2025 |
| Dec 12, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +8,557 | $6.83 | $58k | 1,047,485 | Dec 12, 2025 |
| Dec 11, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -49,959 | $0.00 | $0 | 8,557 | Dec 12, 2025 |
| Dec 12, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,557 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Apr 24, 2025 | IQV IQVIA HOLDINGS INC. | AGrant or award Common Stock | +1,592 | $0.00 | $0 | 15,375 | Apr 25, 2025 |
| Mar 1, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +136,000 | $0.00 | $0 | 1,077,115 | Mar 4, 2025 |
| Mar 1, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +196,000 | $0.00 | $0 | 196,000 | Mar 4, 2025 |
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -26,807 | $12.18 | $327k | 941,115 | Jan 7, 2025 |
| Jan 1, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Common Stock | +7,850 | - | - | 967,922 | Jan 3, 2025 |
| Jan 1, 2025 | NTLA Intellia Therapeutics, Inc. | MOption exercise Restricted Stock Unitderivative | -7,850 | $0.00 | $0 | 0 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.